Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06567470
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-16
Brief Title:
A Study With CIT-013 in RA Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 2a Double Blind Randomized Parallel Arm Placebo-controlled Trial to Investigate the Effects of Two Dose Levels of CIT-013 on Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis RA
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to learn if CIT-013 works to treat rheumatoid arthritis in adults It will also learn about the safety of CIT-013 The main questions it aims to answer are
Does CIT-013 lower the disease activity of RA patients What medical problems do participants have when receiving CIT-013 Researchers will compare CIT-013 to a placebo a look-alike substance that contains no drug to see if CIT-013 works to treat the symptoms of RA
Participants will
Take receive CIT-013 or placebo every other week for 12 weeks Visit the clinic once every 2 weeks for checkups and tests Keep monitor their symptoms during this period
Does CIT-013 lower the disease activity of RA patients What medical problems do participants have when receiving CIT-013 Researchers will compare CIT-013 to a placebo a look-alike substance that contains no drug to see if CIT-013 works to treat the symptoms of RA
Participants will
Take receive CIT-013 or placebo every other week for 12 weeks Visit the clinic once every 2 weeks for checkups and tests Keep monitor their symptoms during this period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None